...
首页> 外文期刊>Clinical advances in hematology & oncology: H&O >Adverse Events Associated With Intravenous Iron Preparations: A Comparison of Reported Rates
【24h】

Adverse Events Associated With Intravenous Iron Preparations: A Comparison of Reported Rates

机译:与静脉铁制剂相关的不良事件:报道的发生率比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

H&O What are the most common intravenous iron preparations used in the United States?GB Several intravenous (IV) iron preparations are widely used in the United States. Iron dextran is available in 2 variants: high-molecular weight (Dexferrum, American Regent) and low-molecular weight (INFeD, Watson). Sodium ferric gluconate is available in its original version (Ferrlecit, Sanofi-Aventis) and a newer generic formulation (Nulecit, Watson). Other preparations are iron sucrose (Venofer, American Regent/Fresenius Medical Care) and the newest agent, ferumoxytol (Feraheme, AMAG), which was approved in 2009. There are some significant differences among these iron preparations, which I will discuss.
机译:H&O在美国使用的最常见的静脉铁制剂是什么?GB在美国广泛使用几种静脉(IV)铁制剂。右旋糖酐铁有两种变体:高分子量(Dexferrum,American Regent)和低分子量(INFeD,Watson)。葡萄糖酸铁钠有其原始版本(Ferrlecit,Sanofi-Aventis)和更新的通用配方(Nulecit,Watson)。其他制剂还有蔗糖铁(Venofer,美国Regent / Fresenius Medical Care)和最新的药剂Ferumoxytol(Feraheme,AMAG),该制剂已于2009年获得批准。我将讨论这些铁制剂之间的显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号